Cabaletta Bio (CABA) Current Assets (2018 - 2025)

Cabaletta Bio's Current Assets history runs 8 years deep, the most recent figure standing at $138.9 million for Q4 2025.

• In Q4 2025, Current Assets fell 16.68% year-over-year to $138.9 million; the TTM figure through Dec 2025 stood at $138.9 million (down 16.68% YoY), while the FY2025 annual figure was $138.9 million, down 16.68% from the prior year.
• Current Assets was $138.9 million for Q4 2025 at Cabaletta Bio, down from $164.6 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $244.5 million in Q4 2023 to a low of $88.2 million in Q3 2022.
• Historically, Current Assets has averaged $148.5 million across 5 years, with a median of $136.7 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Current Assets jumped 137.62% in 2024, then sank 40.83% in 2025.
• A 5-year view of Current Assets shows it stood at $124.5 million in 2021, then fell by 12.61% to $108.8 million in 2022, then soared by 124.64% to $244.5 million in 2023, then plunged by 31.83% to $166.7 million in 2024, then dropped by 16.68% to $138.9 million in 2025.
• The last three Current Assets figures came in at $138.9 million (Q4 2025), $164.6 million (Q3 2025), and $198.4 million (Q2 2025), per Business Quant data.